ushamwari

« Dzokera kuPipeline

Shamwari:

yhan-logo-web

Asset Type:

Immuno-Oncology

Partner Background:

Yuhan Corporation ndeimwe yemakambani makuru ekuKorea emishonga, yakavambwa makore anopfuura makumi masere apfuura

Kudyidzana Details:

Joint Venture inonzi ImmuneOncia Therapeutics, LLC

Yakatarisana nekugadzira uye kushambadzira akati wandei emasoja ekudzivirira ezvirwere zvehematological malignancies uye mamota akasimba.


Shamwari:

Asset Type:

Immuno-Oncology

Partner Background:

Lee's Pharm ikambani yeruzhinji biopharma ine makore anopfuura makumi maviri ekushanda muChina uye parizvino inotengesa zvigadzirwa gumi nemana muPRC.

Kudyidzana Details:

Sorrento ine mvumo yakasarudzika kuLee's Pharm yekugadzira uye kushambadzira iyo yakazara vanhu anti-PD-L1 mAb STI-A1014 yemusika mukuru weChinese.


Shamwari:

celularity-logo-web

Asset Type:

Serura Therapy

Partner Background:

Celularity is spin-off kubva kuCelgene Corporation inotarisa pa placenta-yakatorwa uye tambo-yeropa inotorwa maseru kurapwa.

Kudyidzana Details:

Equity Investment uye Bhodhi Representation


Shamwari:

mabpharm-logo01

Asset Type:

Immuno-oncology

Partner Background:

MABPHARM ikambani yebiopharma inotarisa kuR & D nekugadzirwa kwemishonga mitsva uye "Biobetters" yegomarara nezvirwere zve autoimmune.

Kudyidzana Details:

Sorrento ine rezinesi rakasarudzika rekutengesa maBiobetter mana apedza zvidzidzo zveChikamu 3 muChina kumisika yeNorth America, Europe neJapan.


PaSorrento, isu tinotsvaga kudyidzana kwakasimba uye kubatana semutyairi akakosha wezano redu kusundira miganhu yesainzi uye kuendesa marara-anoshandura marapirwo kuvarwere kuti vararame hupenyu hwakanaka uye hunofadza.